Sponsored by Ultragenyx Pharmaceutical Inc.
| Variant ID | 530 |
|---|---|
| Genomic Coordinate (GRCh38) | g.22212930C>G |
| Variant | c.1672C>G |
| Variant Start Position | 1672 |
| Location | Exon 16 |
| Amino Acid Change | p.Pro558Ala |
| ACMG Call | - |
| ACMG Call Last Revised Date | 4/28/2021 |
| Predicted ACMG Call | Likely Pathogenic | Effect Type | Missense |
| Variant Type | SNV |
| PMID | 18046499, 23813354, 21293852, 24857004, 34806794 |
| Article Count | 5 |
| Times Observed | 3-5 |
| Clinical Phenotype | - |
| ACMG Categories | pm2, pp1, pp3 |
| ACMG Explanations | pm2: chrX:22231047 ref:C alt:G was not found in gnomAD exomes or genomes. pp3: The SIFT, MutationTaster, and PolyPhen predictions agree that this variant is possibly or probably damaging. |
| Variant in Clinvar | No |
| ClinVar Classification | - |
| Categories In Literature | pp1 |
| No Contrary Evidence Found | Yes |
| ExAC Allele Frequency | - |
| Thousand Genomes Allel Frequency | - |
| Ontology Relations | - |
| hg19 Mapping Failed | No |
| Literature Alleles | - |
| GnomAD Alleles | - |
| DBNSFP Alleles | X-22231047-C-G |
| Other Alleles | X-22231047-CCT-GCG X-22231047-CCT-GCC X-22231047-CCT-GCA |
| Note | nan |
| Warnings | - |